Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05181982 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of a Flexible and Integrative Psychiatric Care Model at the Pfalzklinikum (EVA_Pfalz)

Study acronym: EVA_Pfalz
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Study completion pushed from Jul 2026 to Oct 2026
    • Primary completion date changed from estimate of Sep 2025 to Sep 30, 2025
    v6
  2. Minor 2 versions Re-verified since Feb 20, 2024, no change to tracked fieldsv4-v5
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 2022 to Sep 30, 2022
    v3
  4. Minor Secondary endpoints: details revised at 1 of 12 entries
    • Study description shortened, about 14 words
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is an evaluation of the flexible and integrative psychiatric care model (according to § 64b of the German Social Code Book V (SGB V)) (FIT) at the Pfalzklinikum. The central concern of this evaluation is to answer the question whether the FIT model offer advantages over standard care. The orientation of model care is a more cross-sectoral provision of services through more flexible treatment intensities.
Trial Details
NCT Number NCT05181982
Lead Sponsor Technische Universität Dresden
Collaborators: ISMG, Medical Faculty, Otto-von-Guericke University Magdeburg, Scientific Institute for Health Economics and Health System Research
Conditions
(from sponsor)
Mental Health Care
Enrollment 10,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov